These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34676830)

  • 41. Genome-wide gene expression profiling of the Angelman syndrome mice with Ube3a mutation.
    Low D; Chen KS
    Eur J Hum Genet; 2010 Nov; 18(11):1228-35. PubMed ID: 20571502
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bioinformatics analyses show dysregulation of calcium-related genes in Angelman syndrome mouse model.
    Panov J; Kaphzan H
    Neurobiol Dis; 2021 Jan; 148():105180. PubMed ID: 33212289
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Toward a Broader View of Ube3a in a Mouse Model of Angelman Syndrome: Expression in Brain, Spinal Cord, Sciatic Nerve and Glial Cells.
    Grier MD; Carson RP; Lagrange AH
    PLoS One; 2015; 10(4):e0124649. PubMed ID: 25894543
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HAP1 is an in vivo UBE3A target that augments autophagy in a mouse model of Angelman syndrome.
    Wang T; Wang J; Wang J; Mao L; Tang B; Vanderklish PW; Liao X; Xiong ZQ; Liao L
    Neurobiol Dis; 2019 Dec; 132():104585. PubMed ID: 31445164
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mitochondrial dysfunction in CA1 hippocampal neurons of the UBE3A deficient mouse model for Angelman syndrome.
    Su H; Fan W; Coskun PE; Vesa J; Gold JA; Jiang YH; Potluri P; Procaccio V; Acab A; Weiss JH; Wallace DC; Kimonis VE
    Neurosci Lett; 2011 Jan; 487(2):129-33. PubMed ID: 19563863
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Drosophila model for Angelman syndrome.
    Wu Y; Bolduc FV; Bell K; Tully T; Fang Y; Sehgal A; Fischer JA
    Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12399-404. PubMed ID: 18701717
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Angelman syndrome: Current and emerging therapies in 2016.
    Tan WH; Bird LM
    Am J Med Genet C Semin Med Genet; 2016 Dec; 172(4):384-401. PubMed ID: 27860204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Environmental Enrichment Improves Behavioral Abnormalities in a Mouse Model of Angelman Syndrome.
    Jamal I; Kumar V; Vatsa N; Singh BK; Shekhar S; Sharma A; Jana NR
    Mol Neurobiol; 2017 Sep; 54(7):5319-5326. PubMed ID: 27581300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biochemical analysis of Angelman syndrome-associated mutations in the E3 ubiquitin ligase E6-associated protein.
    Cooper EM; Hudson AW; Amos J; Wagstaff J; Howley PM
    J Biol Chem; 2004 Sep; 279(39):41208-17. PubMed ID: 15263005
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome.
    Gustin RM; Bichell TJ; Bubser M; Daily J; Filonova I; Mrelashvili D; Deutch AY; Colbran RJ; Weeber EJ; Haas KF
    Neurobiol Dis; 2010 Sep; 39(3):283-91. PubMed ID: 20423730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome.
    Mulherkar SA; Jana NR
    Neurobiol Dis; 2010 Dec; 40(3):586-92. PubMed ID: 20696245
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spatial and temporal silencing of the human maternal UBE3A gene.
    Daily J; Smith AG; Weeber EJ
    Eur J Paediatr Neurol; 2012 Nov; 16(6):587-91. PubMed ID: 22560727
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rescue of altered HDAC activity recovers behavioural abnormalities in a mouse model of Angelman syndrome.
    Jamal I; Kumar V; Vatsa N; Shekhar S; Singh BK; Sharma A; Jana NR
    Neurobiol Dis; 2017 Sep; 105():99-108. PubMed ID: 28576709
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The spectrum of mutations in UBE3A causing Angelman syndrome.
    Fang P; Lev-Lehman E; Tsai TF; Matsuura T; Benton CS; Sutcliffe JS; Christian SL; Kubota T; Halley DJ; Meijers-Heijboer H; Langlois S; Graham JM; Beuten J; Willems PJ; Ledbetter DH; Beaudet AL
    Hum Mol Genet; 1999 Jan; 8(1):129-35. PubMed ID: 9887341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Of mothers and myelin: Aberrant myelination phenotypes in mouse model of Angelman syndrome are dependent on maternal and dietary influences.
    Grier MD; Carson RP; Lagrange AH
    Behav Brain Res; 2015 Sep; 291():260-267. PubMed ID: 26028516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of cerebellar function in Ube3a-deficient mice reveals novel genotype-specific behaviors.
    Heck DH; Zhao Y; Roy S; LeDoux MS; Reiter LT
    Hum Mol Genet; 2008 Jul; 17(14):2181-9. PubMed ID: 18413322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sleep disturbances in Ube3a maternal-deficient mice modeling Angelman syndrome.
    Colas D; Wagstaff J; Fort P; Salvert D; Sarda N
    Neurobiol Dis; 2005 Nov; 20(2):471-8. PubMed ID: 15921919
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreased tonic inhibition in cerebellar granule cells causes motor dysfunction in a mouse model of Angelman syndrome.
    Egawa K; Kitagawa K; Inoue K; Takayama M; Takayama C; Saitoh S; Kishino T; Kitagawa M; Fukuda A
    Sci Transl Med; 2012 Dec; 4(163):163ra157. PubMed ID: 23220633
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutation Update for UBE3A variants in Angelman syndrome.
    Sadikovic B; Fernandes P; Zhang VW; Ward PA; Miloslavskaya I; Rhead W; Rosenbaum R; Gin R; Roa B; Fang P
    Hum Mutat; 2014 Dec; 35(12):1407-17. PubMed ID: 25212744
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Angelman syndrome protein Ube3a/E6AP is required for Golgi acidification and surface protein sialylation.
    Condon KH; Ho J; Robinson CG; Hanus C; Ehlers MD
    J Neurosci; 2013 Feb; 33(9):3799-814. PubMed ID: 23447592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.